221 related articles for article (PubMed ID: 8695357)
1. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW
Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357
[TBL] [Abstract][Full Text] [Related]
2. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
[TBL] [Abstract][Full Text] [Related]
4. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs.
Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N
Digestion; 1999; 60(3):246-54. PubMed ID: 10343138
[TBL] [Abstract][Full Text] [Related]
5. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.
Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL
Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615
[TBL] [Abstract][Full Text] [Related]
6. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
Parsons SL; Watson SA; Collins HM; Griffin NR; Clarke PA; Steele RJ
Br J Cancer; 1998 Dec; 78(11):1495-502. PubMed ID: 9836483
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
9. Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography.
Mungall BA; Pollitt CC; Collins R
Histochem Cell Biol; 1998 Nov; 110(5):535-40. PubMed ID: 9826133
[TBL] [Abstract][Full Text] [Related]
10. Detection of matrix metalloproteinase activity in human pancreatic cancer.
Koshiba T; Hosotani R; Wada M; Fujimoto K; Lee JU; Doi R; Arii S; Imamura M
Surg Today; 1997; 27(4):302-4. PubMed ID: 9086544
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
Murray GI; Duncan ME; O'Neil P; McKay JA; Melvin WT; Fothergill JE
J Pathol; 1998 Jul; 185(3):256-61. PubMed ID: 9771478
[TBL] [Abstract][Full Text] [Related]
13. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.
Miyajima Y; Nakano R; Morimatsu M
Ann Otol Rhinol Laryngol; 1995 Sep; 104(9 Pt 1):678-84. PubMed ID: 7661515
[TBL] [Abstract][Full Text] [Related]
14. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F
Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672
[TBL] [Abstract][Full Text] [Related]
15. Local activity of matrix metalloproteinases in a case of botryoid sarcoma.
Rechberger T; Postawski K; Skorupski P; Kotarski J; Jakowicki JA
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):169-72. PubMed ID: 8841807
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
[TBL] [Abstract][Full Text] [Related]
17. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection.
Mellanen L; Salo T; Ingman T; Konttinen YT; Lähdevirta J; Sorsa T
Acta Odontol Scand; 1998 Jun; 56(3):135-42. PubMed ID: 9688221
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve.
Kherif S; Dehaupas M; Lafuma C; Fardeau M; Alameddine HS
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):309-19. PubMed ID: 9775397
[TBL] [Abstract][Full Text] [Related]
19. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
[TBL] [Abstract][Full Text] [Related]
20. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
